Arena Pharmaceuticals: How Good Can It Get? [View article]
Great article Mr.Murphy and I enjoy reading about the link about Shane thank you to those who took the time to do that to me it was suspicious that he has been trading since he was 12 I guess he never had a childhood or what? Another thing Shane you are the kind of person that could probably say you started reading when you were 5 months and driving when you were 5 the place you need to go is to Ripley's Believe or not to see if they would believe you!!!!
As A Frustrated Owner Of Vringo Stock, What Should I Do? [View article]
Great Article and Congratulations for being patient with LANG Patience is a virtue and paid off for you with VRNG I have sold and bought but I have some but this ordeal is taking awhile but Puff it can be any day and we don't know that
Arena (ARNA +12.5%) shares continue their upward trajectory ahead of the FDA's decision, which is still nine days away, on whether to approve the company's lorcaserin diet drug. Investors clearly believe the agency will approve the treatment, although market players aren't totally sure why shares are flying so high. [View news story]
@daytrader after eating all the cake I will need to be on one of the obese drugs!!!
It's Time To Dump Apple And Buy Amazon [View article]
I agree with Pts117 this article should say this is a joke I like both stocks but AAPL is a stock that has dropped so much and has a great P/E and pays dividend I don't see that in AMZN I am glad I dropped AMZN
BlackBerry: The Show Hasn't Even Started Yet [View article]
Nice article Ashraf today it is AAPL day though but BBRY is down just a little not much I still do not believe that BBRY might be acquired imho since the laws in Canada are so strict but if the company was located here it would have been sold a long time ago!!!! But they are coming back on their own
After a volatile day featuring trading volume over 5x higher than average, Vringo (VRNG -18%) closed with big losses, as trading ended without a Google settlement announced. A short-lived afternoon rally was attributed to a report of a settlement that would up being discredited, though some remain intrigued by the fact the Vringo-Google trial (set for an Oct. 16 start) no longer appears on a court docket. The fact Vringo's stock offering closed today may have contributed to the volatility. [View news story]
I am not intrigued because they are going to settle outside the court
Western Digital (WDC) guides on its FQ3 earnings call for FQ4 revenue of $4.2B-$4.4B and EPS of $2.35-$2.55. That's above a consensus of $4.19B and $2.30, but isn't enough to satisfy investors given today's massive beat and a 70%+ rally from WDC's November lows. WDC -8.1% AH. Falling in sympathy: STX -4.6%. QTM -2.1%. XRTX -2.4%. [View news story]
WDC Great numbers!! I would not sell low with those numbers!!!!
Ruling Speeds Up End Game In Vringo Settlement [View article]
Google Claims To Have Defeated Vringo Search Patents [View article]
Arena Pharmaceuticals: How Good Can It Get? [View article]
Can Vringo Win 7% Royalties From Google? [View article]
As A Frustrated Owner Of Vringo Stock, What Should I Do? [View article]
Apple Is Falling: Why You Shouldn't Buy The Stock In A Hurry [View article]
Research In Motion (RIMM): FQ2 EPS of -$0.27 beats by $0.19. Revenue of $2.87B (-31% Y/Y) beats by $370M. 7.4M BlackBerry shipments, 130K PlayBooks. Shares +14% AH. (PR) [View news story]
Arena (ARNA +12.5%) shares continue their upward trajectory ahead of the FDA's decision, which is still nine days away, on whether to approve the company's lorcaserin diet drug. Investors clearly believe the agency will approve the treatment, although market players aren't totally sure why shares are flying so high. [View news story]
Google Claims To Have Defeated Vringo Search Patents [View article]
It's Time To Dump Apple And Buy Amazon [View article]
BlackBerry: The Show Hasn't Even Started Yet [View article]
Vringo: Could It Be Worth $2 Billion? [View article]
After a volatile day featuring trading volume over 5x higher than average, Vringo (VRNG -18%) closed with big losses, as trading ended without a Google settlement announced. A short-lived afternoon rally was attributed to a report of a settlement that would up being discredited, though some remain intrigued by the fact the Vringo-Google trial (set for an Oct. 16 start) no longer appears on a court docket. The fact Vringo's stock offering closed today may have contributed to the volatility. [View news story]
Western Digital (WDC) guides on its FQ3 earnings call for FQ4 revenue of $4.2B-$4.4B and EPS of $2.35-$2.55. That's above a consensus of $4.19B and $2.30, but isn't enough to satisfy investors given today's massive beat and a 70%+ rally from WDC's November lows. WDC -8.1% AH. Falling in sympathy: STX -4.6%. QTM -2.1%. XRTX -2.4%. [View news story]
Ruling Speeds Up End Game In Vringo Settlement [View article]